Peter Kolchinsky’s RA Capital Management Bet on $GNTA

Peter Kolchinsky’s RA Capital Management revealed on October 5th that it initiated a brand new position of 42.93 million shares in Genta Incorporated (GNTA). Based on the firm’s 13G on October 5th, RA Capital Management now has 9.99% stake of GNTA’s total outstanding shares. According to Insider Monkey’s hedge funds tracking list, no hedge fund ever had GNTA in portfolio before. GNTA was priced at about $0.5 in January, but in the second quarter the stock dropped to $0.02 when the company could not meet the net tangible asset criteria required for listing on the Nasdaq market. On September 2nd, the stock went down to $0.01. Peter Kolchinsky might regard this as an opportunity to double his investment. It is possible that he made several large purchases before September 9th at $0.01. However, there was no news about GNTA since the end of September. The hope for GNTA’s recovery is still slim.

Peter Kolchinsky

Peter Kolchinsky is the co-founder and general partner of RA Capital Management, LLC. He graduated from Harvard with a Ph.D. in virology and has been investing in healthcare sector since 2002. He successfully turned his initial $4 million investment into $13 million by 2003.

Genta Inc. is a biopharmaceutical company, which mainly develops medicine and treatment for cancer and related diseases. It consists of two major programs: DNA/RNA Medicines and Small Molecules. Genta Inc. is facing a sever debt problem this year due to its heavily loaded with debts balance sheet. The company was founded in 1988 and is based in Berkeley Heights, New Jersey.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!